Swiss pharmaceuticals powerhouse Roche says that it's working to ensure its patients and customers worldwide have access to their medications and diagnostics amid the Trump tariff war.
Switzerland, the land of luxury brands, could see prices skyrocket from Trump's 39% tariffs
→
Roche, in its statement, said that once the new, expanded manufacturing comes on line, the company “will export more medicines from the U.S. than it imports” - though it made no mention of tariffs.
Swiss pharmaceuticals company Roche announces $50 billion investment in U.S. over next five years
→